• Groove Botanicals posted a net loss of $139,917 for fiscal 2026, widening 6.94% from the prior year.
• Loss attributable to common shareholders deepened to $358,387, while basic and diluted loss per share held at $0.01.
• Operating expenses climbed 6.94% to $139,917, led by consulting expense rising to $8,000.
• Cash used in operating activities narrowed to $91,668; cash ended the year at $1,502.
• Management said it has generated no revenue since inception and flagged substantial doubt about its ability to continue as a going concern.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Groove Botanicals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-004080), on June 29, 2026, and is solely responsible for the information contained therein.